Search clinical trials for: Gestodene/EE (FC Patch Low, BAY86-5016)

Total 12 results

Bayer

Completed

US Cycle Control and Blood Pressure Study

Contraception

United States
Bayer

Completed

Investigation of Three Contraceptive Hormone Patches in Regard to Inhibition of Ovulation Following Application Over 3 Treatment Cycles in Healthy, Young Women.

Contraception

Netherlands, Germany
Bayer

Completed

Study Investigating the Efficacy and Safety of a Contraceptive Patch for 13 Cycles

Contraception

United States
Bayer

Completed

Relative Bioavailability, Transdermally Administered EE and GSD, 3 Applications Sites

Contraception

Germany
Bayer

Completed

Russia/Ukraine Suppression of Ovarian Activity Study

Contraception

Russian Federation, Ukraine
Bayer

Completed

FC Patch Low: Metabolism Study

Contraception

Germany
Bayer
Parexel

Completed

Birth Control Patch Study

Contraception

Austria, Czech Republic, Netherlands
Bayer

Completed

US Ovulation Inhibition Study in Obese Women

Contraception

United States
Bayer

Completed

EU/LA Pearl Index Study - Transdermal Contraceptive Patch

Contraception

Italy, Spain, Australia, France, Germany, Argentina, Mexico, Chile
Bayer

Terminated

Inhibition of Ovulation, Patch, Ethinylestradiol and Gestodene

Contraception | Ovulation Inhibition

Germany
Bayer

Completed

Inhibition of Ovulation and Pharmacokinetics of Transdermal Ethinylestradiol (EE) and Gestodene (GSD)

Contraception | Ovulation Inhibition

Germany
Bayer

Completed

Transdermal Contraceptive Patch - Endometrial Effects Study

Contraception

Germany

3

Subscribe